Skip to content

Clinical research study of vallarai nei (Internal medicine) in the treatment of Pithapandu(Iron deficiency Anaemia)

Clinical evaluation of siddha drug Vallarai Nei in the treatment of Pitha Pandu (Iron Deficiency anemia) - IDA

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/01/006557
Enrollment
40
Registered
2016-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PITHA PANDU(IRON DEFICIENCY ANAEMIA)

Interventions

Intervention1: VALLARAI NEI(INTERNAL): Before starting the treatment for PITHA PANDU, purgation will be given with op medicine Meganatha kuligai 2pills (only one time)with ginger juice at early morni

Sponsors

AYOTHIDOSS PANDITHAR HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Hemoglobin level less than normal range For male 7 to 12gms/dl For female 7 to 11gms/dl 2)Patient blood smear shows Microcytic Hypochromic RBC 3)Patient willing to undergo blood investigation 4)Patient willing to sign the Informed consent stating that he/she will conscientiously stick to the treatment during 48days but can opt out of the trial of his/her own conscious discretion

Exclusion criteria

Exclusion criteria: 1)Parasitic infection 2)Pregnancy and lactation 3)History of bronchial asthma 4)History of sinusitis 5)Presence of any severe illness(CA,RA) 6)Endocrine disorder( thyroid abnormality diabetes mellitus) 7)History of cardiac disease 8)History of renal disease 9)Inherited defects like sickle cell anemia thalassemia aplastic anemia 10)Patient not willing to give blood sample 11)Epilepsy

Design outcomes

Primary

MeasureTime frame
Primary outcome is mainly assessed by comparing the pre and post treatment Haemoglobin level of the trial patientTimepoint: Prestudy screening and after treatment

Secondary

MeasureTime frame
It is assessed by comparing following parameters before and after treatment 1)Reduction of clinical symptoms 2)Changes in complete blood count 3)Changes in iron supply studiesTimepoint: Prestudy screening and after treatment

Countries

India

Contacts

Public ContactDR H NALINI SOFIA

NATIONAL INSTITUTE OF SIDDHA

drmohan139@gmail.com044-22411611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026